Sarun Juengpanic (Sarun Juengpanich)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Resistance Training

Systematic Review

Radiofrequency Ablation

Top Venues

Journal of gastroenterology and hepatology

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)
Ming-Yu Chen, Sarun Juengpanic, Shijie Li, Win Topatana, Ziyi Lu, Qiang Zheng, Jiasheng Cao, Jiahao Hu, Esther Chan, Lidan Hou, Jiang Chen, Fang Chen, Yu Liu, Sukanda Jiansirisomboon, Zhen Gu, Suparat Tongpeng, Xiujun Cai
Bortezomib-Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (7) (2022)
Sarun Juengpanic, Win Topatana, Chen Lu, Daniel Staiculescu, Shijie Li, Jiasheng Cao, Jiacheng Lin, Jiahao Hu, Mingyu Chen, Jiang Chen, Xiujun Cai
Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era. International journal of cancer 147 (7) (2020)
Anxin Chen, Shijie Li, Zhiyuan Yao, Jiahao Hu, Jiasheng Cao, Win Topatana, Sarun Juengpanic, Hong Yu, Jiliang Shen, Ming-Yu Chen
Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis. Journal of gastroenterology and hepatology 36 (2) (2020)